MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Optimization of 6-hydroxydopamine animal model of early stage Parkinson´s disease for the assessment of neurorestorative therapies

J.V. Leikas, T.M. Kääriäinen, A.J. Jalkanen, M. Lehtonen, T. Rantamäki, M.M. Forsberg (Kuopio, Finland)

Meeting: 2016 International Congress

Abstract Number: 795

Keywords: Dopamine, Parkinsonism, Striatonigral degeneration

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To optimize a simple unilateral partial 6-hydroxydopamine (6-OHDA) lesion protocol that would produce 40-60% striatal dopamine (DA) depletion with detectable motor deficits and to evaluate the performance of the model by a neurorestorative intervention.

Background: Unilateral 6-OHDA infusion into rat striatum induces partial degeneration of nigrostriatal dopaminergic neurons and sensorimotor deficits that resemble human parkinsonism. Despite the model has been used extensively, optimal lesion protocol producing 40-60% DA depletion for testing of neurorestorative therapies has not been established.

Methods: Various intrastriatal 6-OHDA doses (3-60 µg) were infused unilaterally. Two weeks later, striatal DA depletion was assessed by HPLC. 6-OHDA induced motor deficits were assessed by D-amphetamine (2.5 mg/kg i.p.) induced rotation test, and by a sensorimotor test battery consisting of cylinder, adjusting step and vibrissae tests. On the basis of these studies, an optimal 6-OHDA dose (10 µg) was selected and the neurorestorative effects of walking exercise (30 min x 5 times/week for five weeks) were assessed.

Results: A single 10 µg intrastriatal 6-OHDA infusion produced 40-60% DA depletion in striatum. 6-OHDA dose range (6-14 µg) causing 40-60 % striatal DA depletion induced variable (50-500 ipsilateral rounds) rotational responses in D-amphetamine test. Instead, the ipsilateral limb use score (i.e. the average of ipsilateral limb use preference in the vibrissae, adjusting step and cylinder tests) was sensitive in distinguishing between different degrees of 6-OHDA lesions. The score was also able to detect the progression of motor deficits in the long term walking exercise study, and walking exerted significant neurorestorative effects in the model.

Conclusions: A single 10 µg intrastriatal 6-OHDA infusion can be considered as an optimal dose to induce a consistent partial lesion and it represents an animal model of early PD suitable for testing neurorestorative therapies aimed to restoring the functionality of a damaged nigrostriatal dopaminergic system. The combination of simple sensorimotor tests and overall ipsilateral limb use score provide a powerful means to assess sensorimotor performance of rats with unilateral partial 6-OHDA lesion in testing of the efficacy of novel neurorestorative treatments such as walking exercise in this study.

To cite this abstract in AMA style:

J.V. Leikas, T.M. Kääriäinen, A.J. Jalkanen, M. Lehtonen, T. Rantamäki, M.M. Forsberg. Optimization of 6-hydroxydopamine animal model of early stage Parkinson´s disease for the assessment of neurorestorative therapies [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/optimization-of-6-hydroxydopamine-animal-model-of-early-stage-parkinsons-disease-for-the-assessment-of-neurorestorative-therapies/. Accessed May 21, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/optimization-of-6-hydroxydopamine-animal-model-of-early-stage-parkinsons-disease-for-the-assessment-of-neurorestorative-therapies/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley